Our Stories.
Let’s put patients at the center of impact investing
More investors than ever want their money to make a positive impact on the world while producing a financial return. Reboot Rx’s CEO Laura Kleiman recently moderated the “Investing for Social Impact” panel at the WuXi Global Forum. She shares reflections on how impact investing could fund clinical trials testing new uses for generic drugs.
Social impact bonds could fund drug repurposing clinical trials
Innovative funding models and economic incentives are needed to enable clinical testing of repurposed generic drugs. We spoke with Dr. Rick Thompson, CEO of Findacure, about his experience with the drug repurposing social impact bond in the UK.